<p>Researchers at University Medicine Halle have developed a new method that could improve the reliability of blood tests for Alzheimer's disease. Current commercial tests often rely on the protein biomarker p-tau217, whose levels can rise in the early stages of the disease. However, the biomarker leve</p>